Onset of psoriasis with immune checkpoint inhibitor therapy: A systematic review

被引：3
|
作者：
Tarafdar, Nawar [1 ]
Sachdeva, Muskaan [2 ]
Savinova, Iryna [3 ]
Lytvyn, Yuliya [2 ]
Maliyar, Khalad [2 ]
Georgakopoulos, Jorge R. [2 ]
Mufti, Asfandyar [2 ]
Yeung, Jensen [2 ,4 ]
机构：
[1] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[2] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[3] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[4] Womens Coll Hosp, Div Dermatol, 76 Grenville St, 5th Floor, Toronto, ON, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 90卷 / 02期
关键词：
atezolizumab; camrelizumab; cemiplimab; durvalumab; immune checkpoint inhibitor; immunotherapy; ipilimumab; nivolumab; pembrolizumab; psoriasis; systematic review;
D O I：
10.1016/j.jaad.2023.09.070
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：392 / 395
页数：4
相关论文
共 50 条
  • [31] Diagnosis of immune checkpoint inhibitor-associated myocarditis: A systematic review
    Pradhan, Richeek
    Nautiyal, Amit
    Singh, Sonal
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 296 : 113 - 121
  • [32] Immune Checkpoint Inhibitor Therapy Toxicities
    Jim, Heather S. L.
    Knoop, Hans
    Dicker, Adam P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (01): : 87 - 87
  • [33] Immune checkpoint inhibitor therapy for recurrent meningiomas: a retrospective chart review
    Nidamanuri, Priya
    Drappatz, Jan
    JOURNAL OF NEURO-ONCOLOGY, 2022, 157 (02) : 271 - 276
  • [34] Immune checkpoint inhibitor therapy for recurrent meningiomas: a retrospective chart review
    Priya Nidamanuri
    Jan Drappatz
    Journal of Neuro-Oncology, 2022, 157 : 271 - 276
  • [35] A Systematic Review of Treatment-Related Adverse Events for Combination Therapy of Multiple Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor
    Sawada, Takashi
    Narukawa, Mamoru
    CANCER CONTROL, 2024, 31
  • [36] Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features
    Ellis, Samantha R.
    Vierra, Aren T.
    Millsop, Jillian W.
    Lacouture, Mario E.
    Kiuru, Maija
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (04) : 1130 - 1143
  • [37] Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy
    Durbin, Sienna M.
    Zubiri, Leyre
    Perlman, Katherine
    Wu, Chia-Yun
    Lim, Tristan
    Grealish, Kelley
    Hathaway, Nora
    Lopiccolo, Jaclyn
    Wang, Mike
    Falade, Ayo
    Molina, Gabriel
    Jacoby, Ted Victor
    Shah, Nishi
    Mooradian, Meghan J.
    Reynolds, Kerry L.
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [38] The efficacy and safety of solid tumors combination therapy with immune checkpoint inhibitor: A systematic review and meta-analysis
    Peng, M.
    Weng, Y.
    Yao, Y.
    Song, Q.
    ANNALS OF ONCOLOGY, 2018, 29
  • [39] The use of patient reported outcome (PRO) instruments in immune checkpoint inhibitor (ICI) therapy for cancer: A systematic review
    Colomer-Lahiguera, S.
    Bryant-Lukosius, D.
    Rietkoetter, S.
    Martelli, L.
    Ribi, K.
    Orcurto, A.
    Juergens, R.
    Eicher, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [40] The impact of cannabis on immune checkpoint inhibitor therapy: a systematic review of immunomodulatory effects of cannabis in patients with and without cancer
    Behling-Hess, Caroline
    Simonson, Grant
    Salz, Talya
    Fleege, Nicole
    Zylla, Dylan
    SUPPORTIVE CARE IN CANCER, 2025, 33 (03)
12345